OS Therapies Incorporated (OSTX) Stock price, Description, News & Info
#Thinksabio latest news OS Therapies Announces Last Patient Enrolled in OST-504 (previously ADXS-504) Phase 1b...
#Thinksabio latest news OS Therapies Announces Last Patient Enrolled in OST-504 (previously ADXS-504) Phase 1b...
#Thinksabio latest news TON Strategy Company Announces Initial Share Repurchases Under $250 Million Program, Buying...
#Thinksabio latest news House of Doge Official Dogecoin Treasury Partner CleanCore Acquires Over 500 Million...
#Thinksabio latest news Wearable Devices Announces Pricing of $4 Million Registered Direct Offering and Concurrent...
#Thinksabio latest news Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker...
#Thinksabio latest news FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse...
#Thinksabio latest news Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming...
#Thinksabio latest news CLPS Incorporation Leverages AI for Successful Legacy System Modernization at a Major...
#Thinksabio latest news Silynxcom Receives Over $750,000 Tactical Communication Headset Order from the Israel Defense...
#Thinksabio latest news GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a...